Likewise, Lactobacillus rhamnosus GG demonstrated similar benefits, enhancing responses to anti-PD-1 in melanoma and colon cancer mouse models by triggered type I interferon (IFN) production in dendritic cell, leading to enhancing the cross-priming of antitumor CD8+ T cells (80). Here, PDCD1 is linked to melanoma.